Chaudhary, B., Khaled, Y. S., Ammori, B. J., & Elkord, E. (2014). Neuropilin 1: function and therapeutic potential in cancer. Cancer Immunology, Immunotherapy, 63, 81–99.

Article  CAS  PubMed  Google Scholar 

Parker, M. W., Linkugel, A. D., & Vander Kooi, C. W. (2013). Effect of C-terminal sequence on competitive semaphorin binding to neuropilin-1. Journal of Molecular Biology, 425, 4405–4414.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nasarre, P., Gemmill, R. M., & Drabkin, H. A. (2014). The emerging role of class-3 semaphorins and their neuropilin receptors in oncology. OncoTargets and Therapy, 7, 1663–1687.

PubMed  PubMed Central  Google Scholar 

Liu, S. D., Zhong, L. P., He, J., & Zhao, Y. X. (2020). Targeting neuropilin-1 interactions is a promising anti-tumor strategy. Chinese Medical Journal, 134, 508–517.

Article  PubMed  PubMed Central  Google Scholar 

Rizzolio, S., Rabinowicz, N., Rainero, E., Lanzetti, L., Serini, G., Norman, J., Neufeld, G., & Tamagnone, L. (2012). Neuropilin-1-dependent regulation of EGF-receptor signaling. Cancer Research, 72, 5801–5811.

Article  CAS  PubMed  Google Scholar 

Matsushita, A., Gotze, T., & Korc, M. (2007). Hepatocyte growth factor-mediated cell invasion in pancreatic cancer cells is dependent on neuropilin-1. Cancer Research, 67, 10309–10316.

Article  CAS  PubMed  Google Scholar 

De Luca, A., Carotenuto, A., Rachiglio, A., Gallo, M., Maiello, M. R., Aldinucci, D., Pinto, A., & Normanno, N. (2008). The role of the EGFR signaling in tumor microenvironment. Journal of Cellular Physiology, 214, 559–567.

Article  PubMed  Google Scholar 

Bielenberg, D. R., Pettaway, C. A., Takashima, S., & Klagsbrun, M. (2006). Neuropilins in neoplasms: expression, regulation, and function. Experimental Cell Research, 312, 584–593.

Article  CAS  PubMed  Google Scholar 

Sulpice, E., Plouet, J., Berge, M., Allanic, D., Tobelem, G., & Merkulova-Rainon, T. (2008). Neuropilin-1 and neuropilin-2 act as coreceptors, potentiating proangiogenic activity. Blood, 111, 2036–2045.

Article  CAS  PubMed  Google Scholar 

Wang, J., Huang, Y., Zhang, J., Xing, B., Xuan, W., Wang, H., Huang, H., Yang, J., & Tang, J. (2018). NRP-2 in tumor lymphangiogenesis and lymphatic metastasis. Cancer Letters, 418, 176–184.

Article  CAS  PubMed  Google Scholar 

Bondeva, T., & Wolf, G. (2015). Role of neuropilin-1 in diabetic nephropathy. Journal of Clinical Medicine, 4, 1293–1311.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nakamura, F., & Goshima, Y. (2002). Structural and functional relation of neuropilins. Advances in Experimental Medicine and Biology, 515, 55–69.

Article  CAS  PubMed  Google Scholar 

Gu, C., Limberg, B. J., Whitaker, G. B., Perman, B., Leahy, D. J., Rosenbaum, J. S., Ginty, D. D., & Kolodkin, A. L. (2002). Characterization of neuropilin-1 structural features that confer binding to semaphorin 3A and vascular endothelial growth factor 165. Journal of Biological Chemistry, 277, 18069–18076.

Article  CAS  PubMed  Google Scholar 

Glinka, Y., & Prud’homme, G. J. (2008). Neuropilin-1 is a receptor for transforming growth factor beta-1, activates its latent form, and promotes regulatory T cell activity. Journal of Leukocyte Biology, 84, 302–310.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hang, C., Yan, H. S., Gong, C., Gao, H., Mao, Q. H., & Zhu, J. X. (2019). MicroRNA-9 inhibits gastric cancer cell proliferation and migration by targeting neuropilin-1. Experimental and Therapeutic Medicine, 18, 2524–2530.

CAS  PubMed  PubMed Central  Google Scholar 

Zhou, R., Curry, J. M., Roy, L. D., Grover, P., Haider, J., Moore, L. J., Wu, S. T., Kamesh, A., Yazdanifar, M., Ahrens, W. A., Leung, T., & Mukherjee, P. (2016). A novel association of neuropilin-1 and MUC1 in pancreatic ductal adenocarcinoma: role in induction of VEGF signaling and angiogenesis. Oncogene, 35, 5608–5618.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hendricks, C., Dubail, J., Brohee, L., Delforge, Y., Colige, A., & Deroanne, C. (2016). A novel physiological glycosaminoglycan-deficient splice variant of neuropilin-1 Is anti-tumorigenic in vitro and in vivo. PLoS ONE, 11, e0165153.

Article  PubMed  PubMed Central  Google Scholar 

Al-Shareef, H., Hiraoka, S. I., Tanaka, N., Shogen, Y., Lee, A. D., Bakhshishayan, S., & Kogo, M. (2016). Use of NRP1, a novel biomarker, along with VEGF-C, VEGFR-3, CCR7 and SEMA3E, to predict lymph node metastasis in squamous cell carcinoma of the tongue. Oncology Reports, 36, 2444–2454.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jimenez-Hernandez, L. E., Vazquez-Santillan, K., Castro-Oropeza, R., Martinez-Ruiz, G., Munoz-Galindo, L., Gonzalez-Torres, C., Cortes-Gonzalez, C. C., Victoria-Acosta, G., Melendez-Zajgla, J., & Maldonado, V. (2018). NRP1-positive lung cancer cells possess tumor-initiating properties. Oncology Reports, 39, 349–357.

CAS  PubMed  Google Scholar 

Jubb, A. M., Strickland, L. A., Liu, S. D., Mak, J., Schmidt, M., & Koeppen, H. (2012). Neuropilin-1 expression in cancer and development. The Journal of Pathology, 226, 50–60.

Article  CAS  PubMed  Google Scholar 

Soker, S., Miao, H. Q., Nomi, M., Takashima, S., & Klagsbrun, M. (2002). VEGF165 mediates formation of complexes containing VEGFR-2 and neuropilin-1 that enhance VEGF165-receptor binding. Journal of Cellular Biochemistry, 85, 357–368.

Article  CAS  PubMed  Google Scholar 

Soker, S., Takashima, S., Miao, H. Q., Neufeld, G., & Klagsbrun, M. (1998). Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell, 92, 735–745.

Article  CAS  PubMed  Google Scholar 

Keyt, B. A., Nguyen, H. V., Berleau, L. T., Duarte, C. M., Park, J., Chen, H., & Ferrara, N. (1996). Identification of vascular endothelial growth factor determinants for binding KDR and FLT-1 receptors. Generation of receptor-selective VEGF variants by site-directed mutagenesis. Journal of Biological Chemistry, 271, 5638–5646.

Article  CAS  PubMed  Google Scholar 

Arkin, M. R., & Wells, J. A. (2004). Small-molecule inhibitors of protein-protein interactions: progressing towards the dream. Nature Reviews Drug Discovery, 3, 301–317.

Article  CAS  PubMed  Google Scholar 

Jia, H., Aqil, R., Cheng, L., Chapman, C., Shaikh, S., Jarvis, A., Chan, A. W., Hartzoulakis, B., Evans, I. M., Frolov, A., Martin, J., Frankel, P., Djordevic, S., Zachary, I. C., & Selwood, D. L. (2014). N-terminal modification of VEGF-A C terminus-derived peptides delineates structural features involved in neuropilin-1 binding and functional activity. Chembiochem, 15, 1161–1170.

Article  CAS  PubMed  Google Scholar 

Jarvis, A., Allerston, C. K., Jia, H., Herzog, B., Garza-Garcia, A., Winfield, N., Ellard, K., Aqil, R., Lynch, R., Chapman, C., Hartzoulakis, B., Nally, J., Stewart, M., Cheng, L., Menon, M., Tickner, M., Djordjevic, S., Driscoll, P. C., Zachary, I., & Selwood, D. L. (2010). Small molecule inhibitors of the neuropilin-1 vascular endothelial growth factor A (VEGF-A) interaction. Journal of Medicinal Chemistry, 53, 2215–2226.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jia, H., Bagherzadeh, A., Hartzoulakis, B., Jarvis, A., Lohr, M., Shaikh, S., Aqil, R., Cheng, L., Tickner, M., Esposito, D., Harris, R., Driscoll, P. C., Selwood, D. L., & Zachary, I. C. (2006). Characterization of a bicyclic peptide neuropilin-1 (NP-1) antagonist (EG3287) reveals importance of vascular endothelial growth factor exon 8 for NP-1 binding and role of NP-1 in KDR signaling. Journal of Biological Chemistry, 281, 13493–13502.

Article  CAS  PubMed  Google Scholar 

Starzec, A., Miteva, M. A., Ladam, P., Villoutreix, B. O., & Perret, G. Y. (2014). Discovery of novel inhibitors of vascular endothelial growth factor-A-Neuropilin-1 interaction by structure-based virtual screening. Bioorganic & Medicinal Chemistry, 22, 4042–4048.

Article  CAS  Google Scholar 

Grabowska, K., Puszko, A. K., Lipinski, P. F., Laskowska, A. K., Wilenska, B., Witkowska, E., Perret, G. Y., & Misicka, A. (2017). Structure-activity relationship study of a small cyclic peptide H-c[Lys-Pro-Glu]-Arg-OH: a potent inhibitor of vascular endothelial growth factor interaction with neuropilin-1. Bioorganic & Medicinal Chemistry, 25, 597–602.

Article